Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate

Cancer. 1970 Aug;26(2):249-56. doi: 10.1002/1097-0142(197008)26:2<249::aid-cncr2820260202>3.0.co;2-7.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Acid Phosphatase / blood
  • Aged
  • Carcinoma / drug therapy*
  • Carcinoma / mortality
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / mortality
  • Cerebrovascular Disorders / complications
  • Clinical Trials as Topic
  • Diethylstilbestrol / adverse effects*
  • Electrocardiography
  • Heart Failure / complications
  • Humans
  • Ischemia / complications
  • Male
  • Myocardial Infarction / complications
  • Neoplasm Metastasis
  • Placebos
  • Plasminogen / metabolism
  • Prognosis
  • Prostate / metabolism
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Pulmonary Embolism / complications

Substances

  • Placebos
  • Diethylstilbestrol
  • Plasminogen
  • Acid Phosphatase